---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-25-000142"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2025-12-10T23:59:59+00:00"
generated_at: "2026-05-16T13:37:17.597921+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Elevance Health elects Amy Schulman as independent director effective Jan 12, 2026

## Summary
- Amy Schulman, Managing Partner at Polaris Partners, joins Elevance Health board.
- Appointed to Audit and Finance Committees; effective January 12, 2026.
- Schulman also chairs Alnylam Pharmaceuticals board and is senior lecturer at Harvard Business School.
- Board cites ongoing refreshment strategy; Schulman brings healthcare, governance, and investment expertise.

## SEC filing metadata
- accession: 0001156039-25-000142
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2025-12-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000142/0001156039-25-000142-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000142/elv-20251210.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-25-000142
- JSON: https://secwatch.observer/filing/0001156039-25-000142.json
- Plain text: https://secwatch.observer/filing/0001156039-25-000142.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.